Literature DB >> 15257297

Muscleblind proteins regulate alternative splicing.

Thai H Ho1, Nicolas Charlet-B, Michael G Poulos, Gopal Singh, Maurice S Swanson, Thomas A Cooper.   

Abstract

Although the muscleblind (MBNL) protein family has been implicated in myotonic dystrophy (DM), a specific function for these proteins has not been reported. A key feature of the RNA-mediated pathogenesis model for DM is the disrupted splicing of specific pre-mRNA targets. Here we demonstrate that MBNL proteins regulate alternative splicing of two pre-mRNAs that are misregulated in DM, cardiac troponin T (cTNT) and insulin receptor (IR). Alternative cTNT and IR exons are also regulated by CELF proteins, which were previously implicated in DM pathogenesis. MBNL proteins promote opposite splicing patterns for cTNT and IR alternative exons, both of which are antagonized by CELF proteins. CELF- and MBNL-binding sites are distinct and regulation by MBNL does not require the CELF-binding site. The results are consistent with a mechanism for DM pathogenesis in which expanded repeats cause a loss of MBNL and/or gain of CELF activities, leading to misregulation of alternative splicing of specific pre-mRNA targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257297      PMCID: PMC514918          DOI: 10.1038/sj.emboj.7600300

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  54 in total

1.  A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing.

Authors:  A D Polydorides; H J Okano; Y Y Yang; G Stefani; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.

Authors:  A N Ladd; N Charlet; T A Cooper
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.

Authors:  N A Timchenko; A L Welm; X Lu; L T Timchenko
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

4.  Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.

Authors:  S Michalowski; J W Miller; C R Urbinati; M Paliouras; M S Swanson; J Griffith
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

5.  Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

Authors:  W S Lai; E Carballo; J R Strum; E A Kennington; R S Phillips; P J Blackshear
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

7.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator.

Authors:  P J Good; Q Chen; S J Warner; D C Herring
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

9.  Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors.

Authors:  W Jin; I E McCutcheon; G N Fuller; E S Huang; G J Cote
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

10.  RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.

Authors:  N A Timchenko; Z J Cai; A L Welm; S Reddy; T Ashizawa; L T Timchenko
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

View more
  229 in total

Review 1.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 2.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

3.  Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis.

Authors:  Bjarke Feenstra; Frank Geller; Camilla Krogh; Mads V Hollegaard; Sanne Gørtz; Heather A Boyd; Jeffrey C Murray; David M Hougaard; Mads Melbye
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

4.  Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.

Authors:  Devika P Gates; Leslie A Coonrod; J Andrew Berglund
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

5.  Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.

Authors:  Raman Parkesh; Jessica L Childs-Disney; Masayuki Nakamori; Amit Kumar; Eric Wang; Thomas Wang; Jason Hoskins; Tuan Tran; David Housman; Charles A Thornton; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2012-03-05       Impact factor: 15.419

Review 6.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

7.  Solution structure of the RNA binding domain in the human muscleblind-like protein 2.

Authors:  Fahu He; Weirong Dang; Chikage Abe; Kengo Tsuda; Makoto Inoue; Satoru Watanabe; Naohiro Kobayashi; Takanori Kigawa; Takayoshi Matsuda; Takashi Yabuki; Masaaki Aoki; Eiko Seki; Takushi Harada; Yuri Tomabechi; Takaho Terada; Mikako Shirouzu; Akiko Tanaka; Peter Güntert; Yutaka Muto; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

8.  A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Authors:  Auinash Kalsotra; Xinshu Xiao; Amanda J Ward; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 9.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

10.  Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice.

Authors:  Samuel T Carrell; Ellie M Carrell; David Auerbach; Sanjay K Pandey; C Frank Bennett; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2016-08-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.